Generated by AI
HeartSciences Inc. is a medical technology company focused on artificial intelligence-enhanced electrocardiography. The company develops AI-ECG solutions designed to improve the clinical usefulness of standard ECG testing by helping detect cardiac dysfunction and related heart conditions earlier in care pathways. Its current product set includes the MyoVista wavECG device, a resting 12-lead ECG that combines conventional rhythm and diagnostic information in a single test, and MyoVista Insights, a cloud-native ECG management platform that is designed to work across different device and vendor environments. HeartSciences serves healthcare settings where rapid cardiac screening and interpretation are important, including frontline and point-of-care environments. Founded in 2007 and headquartered in Southlake, Texas, the company positions itself within the healthcare information technology and medical devices market, with a focus on practical ECG enhancement rather than replacing existing clinical workflows.
Website550 Reserve Street
Southlake, TX, 76092
United States
The latest articles about HSCS.
HeartSciences (HSCS) proposed merger partner Fortitude Mining has amended its existing credit facili
Summary of Oct 6's posts. Generated by AI.
Summary of Jun 23's posts. Generated by AI.
Detailed price information for Heartsciences Inc (HSCS-Q) from The Globe and Mail including charting and trades.
Summary of Jun 23's posts. Generated by AI.
Investors talking about HSCS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.